Axis Mutual FundEquity Schemes - Large & Mid Cap Fund8 years
The scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of Equity & Equity Related Instruments both in India as well as overseas.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 61% of rolling 1-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer JM Large & Mid Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
8.0 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.83% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -31.9%. Ask whether you can hold through a similar fall.
Vs category
Watch
50% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Mayank Hyanki · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 26.7% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 32%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
13 Feb 2020 – 24 Aug 2020
Trough 23 Mar 2020 · recovered in 154 days
-31.9%
18 Oct 2021 – 2 Jun 2023
Trough 20 Jun 2022 · recovered in 347 days
-21.3%
24 Sept 2024 – 20 Oct 2025
Trough 7 Apr 2025 · recovered in 196 days
-17.2%
29 Oct 2025 – 27 May 2026
Trough 30 Mar 2026 · recovered in 58 days
-12.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
71
Vs category
77
Consistency
56
Risk-adjusted
66
Drawdown
20
Mean
58
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
30 Sept 2026 · 106 holdings · top 10 are 26.7%.
ICICI Bank Ltd
Financial
4.4%
HDFC Bank Ltd
Financial
3.4%
Divi's Laboratories Ltd
Healthcare
2.8%
Zomato Ltd
Technology
2.7%
Others CBLO
Unspecified
2.5%
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
JM Financial Mutual Fund
Caveat: Higher TER · Lower trailing returns
WhiteOak Capital Mutual Fund
Caveat: Higher TER · Lower trailing returns
Helios Mutual Fund
Caveat: Higher volatility · Higher TER · Lower trailing returns
HSBC Mutual Fund
Caveat: Higher volatility · Deeper drawdown · Higher TER
Bajaj Finserv Mutual Fund
Caveat: Higher TER · Lower trailing returns
Axis Mutual FundEquity Schemes - Large & Mid Cap Fund8 years
The scheme seeks to generate long term capital appreciation by investing in a diversified portfolio of Equity & Equity Related Instruments both in India as well as overseas.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 61% of rolling 1-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer JM Large & Mid Cap Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Pass
8.0 years of path to read.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.83% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -31.9%. Ask whether you can hold through a similar fall.
Vs category
Watch
50% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Watch
Mayank Hyanki · 0.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 26.7% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 32%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
29 Oct 2026 · -0.3% over 1Y
37.20
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
29 Oct 2026
-6.3%
13 Feb 2020 – 24 Aug 2020
Trough 23 Mar 2020 · recovered in 154 days
-31.9%
18 Oct 2021 – 2 Jun 2023
Trough 20 Jun 2022 · recovered in 347 days
-21.3%
24 Sept 2024 – 20 Oct 2025
Trough 7 Apr 2025 · recovered in 196 days
-17.2%
29 Oct 2025 – 27 May 2026
Trough 30 Mar 2026 · recovered in 58 days
-12.3%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
71
Vs category
77
Consistency
56
Risk-adjusted
66
Drawdown
20
Mean
58
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
30 Sept 2026 · 106 holdings · top 10 are 26.7%.
ICICI Bank Ltd
Financial
4.4%
HDFC Bank Ltd
Financial
3.4%
Divi's Laboratories Ltd
Healthcare
2.8%
Zomato Ltd
Technology
2.7%
Others CBLO
Unspecified
2.5%